4,5-Dihydro-1H-1,5-methanobenzo[d]azepin-2(3H)-one

Catalog No. :
ACOINM846
CAS No. :
357426-13-2
Molecular Formula :
C11H11NO
Molecular Weight :
173.21

IUPAC Name:1,3,4,5-tetrahydro-2H-1,5-methanobenzo[d]azepin-2-one

4,5-Dihydro-1H-1,5-methanobenzo[d]azepin-2(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$78.00Login to see priceIn stockInquiry
1g95%$210.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5-Dihydro-1H-1,5-methanobenzo[d]azepin-2(3H)-one
IUPAC Name1,3,4,5-tetrahydro-2H-1,5-methanobenzo[d]azepin-2-one
MDL No.MFCD13248597
Molecular FormulaC11H11NO
Molecular Weight173.21
SMILESO=C1NCC2C3=CC=CC=C3C1C2
InChI KeyDTPZUFKPINOVKL-UHFFFAOYSA-N
Synonym1,3,4,5-Tetrahydro-1,5-methano-2H-3-benzazepin-2-one;1,5-Methano-2H-3-benzazepin-2-one, 1,3,4,5-tetrahydro-;4,5-Dihydro-1H-1,5-Methanobenzo[d]azepin-2(3H)-one;1,5-Methano-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepine;1,3,4,5-tetrahydro-2H-1,5-methano-3-benzazepin-2-one
CAS No.357426-13-2
PubChem CID10130184

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACOINM846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOINM846 route product structure diagram
    ACOINM846357426-13-2 In Stock
Inquiry

2. ACOINM846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBFSC511 route compound structure diagram
    ACBFSC51143086-58-4
  6. Then
  7. ACOINM846 route product structure diagram
    ACOINM846357426-13-2 In Stock
Inquiry

Comments (0)